EZH2 mutations frequently occur in myeloproliferative/myeloproliferative neoplasms, myelodysplastic syndromes, and myelofibrosis, while CML cases are mainly characterized by EZH2 overexpression [18]. This evidence concerns the gene EZH2 and myelofibrosis.